Skip to main content
PIII
NASDAQ Industrial Applications And Services

P3 Health Partners Posts $30.8M Q3 Net Income, Lifts FY26 Adjusted EBITDA Midpoint to $100M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$4.25
Mkt Cap
$31.3M
52W Low
$1.52
52W High
$16.89
52W Position info
180% above low
Off High info
75% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

PIII has more than doubled off its 52-week low of $1.52.

Summary

P3 Health Partners reported Q3 revenue of $396 million and net income of $30.8 million, and raised the low end of its 2026 Adjusted EBITDA guidance to $90 million, lifting the midpoint to $100 million.


Key Events · Earnings and Guidance · PIII

  • Q3 Profit Swing

    Net income of $30.8 million versus a $69.5 million net loss in the prior-year quarter, on total revenue of $396 million, up 15% year over year.

  • Guidance Midpoint Raised

    Full-year 2026 Adjusted EBITDA is now guided to a $90 million to $110 million range, a $100 million midpoint, with the low end raised from prior guidance.

  • Margin Boost Is Partly One-Off

    Medical margin of $43.9 million ($140 PMPM) included favorable payer settlements and prior-year development; excluding those items it was $35.0 million ($111 PMPM).

  • Cash Position Improves

    Cash stood at $43.9 million at September 30, 2026 versus $25.0 million at December 31, 2025, after the preferred stock and warrant financing.


Analysis · PIII · Industrial Applications And Services

The headline swing is stark: a $69.5 million net loss a year ago became $30.8 million of net income on $396 million of revenue, and management raised the low end of full-year Adjusted EBITDA guidance to $90 million, lifting the midpoint to $100 million. Quality is the catch. Medical margin of $43.9 million included favorable payer settlements and prior-year development; strip those out and it was $35.0 million. A going-concern risk factor and a large preferred/warrant overhang from the September financing also remain, so the profit is real but the capital structure still dominates the equity story.

How filings like this one have moved

In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PIII was trading at $4.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $31.3M. The 52-week trading range was $1.52 to $16.89. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PIII - Latest Insights

PIII
Nov 09, 2026, 4:46 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.25
Real-time Price: $4.25 info
Change: $0 (0%) info
Market Cap: $31.3M info
PIII
Nov 09, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $4.25
Real-time Price: $4.25 info
Change: $0 (0%) info
Market Cap: $31.3M info
PIII
Oct 14, 2026, 7:44 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $4.37
Real-time Price: $4.25 info
Change: -$0.120 (-3%) info
Market Cap: $31.3M info
PIII
Sep 11, 2026, 4:28 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.43
Real-time Price: $4.25 info
Change: -$4.18 (-50%) info
Market Cap: $31.3M info
PIII
Aug 12, 2026, 4:30 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $11.82
Real-time Price: $4.25 info
Change: -$7.57 (-64%) info
Market Cap: $31.3M info